The pivotal trial, published in the New England Journal of Medicine , randomly assigned 412 patients with HIV, 86% of whom were men and all of whom had abdominal fat accumulation, to receive a daily subcutaneous injection of either 2 mg of tesamorelin or placebo for 26 weeks, with the primary endpoint being percent change in visceral adipose tissue as measured by CT scan
H.AldubayanM
Consequently, the expression of GSH and GPX4 increases, which suppresses ROS accumulation and the generation of MDA, ultimately alleviating the pain and depressive symptoms in CCI and CUMS rats through the inhibition of ferroptosis (YANG R
The preclinical numbers stand out: ~5% total body weight reduction in just 11 days, with 35% less white fat, 30% lower cholesterol, and no change in food intake
It may appeal to individuals interested in advanced delivery formats and foundational nutritional support
Very happy because it works